Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

University Marks Official Opening of New Biomedical Research Facility

Published: Monday, July 15, 2013
Last Updated: Monday, July 15, 2013
Bookmark and Share
The Allam Building, home to a new biomedical research facility tackling cancer and other major diseases, is to be officially opened at the University’s Hull Campus.

Two research centres, one focusing on cardiovascular and metabolic diseases and the other on cancer are located in the building. The University has an international reputation in both of these areas, and by bringing together both academics and health professionals, it aims to quickly translate research into tangible benefits for patients.

Professor John Greenman, Head of the School of Biological, Biomedical and Environmental Sciences, said: “It has been a pleasure to watch this fantastic facility develop from an idea through to reality. The new facilities provide the University of Hull with a significant boost to our research capabilities to tackle cancer and cardiovascular disease. The building provides a physical home for our current and future collaborative work.”

The building has been made possible by a generous £1.5 million donation from leading East Yorkshire businessman, Dr Assem Allam. It will be officially opened by Sir Paul Nurse, President of the Royal Society, Nobel Prize winner and an honorary graduate of the University. Funding for some of the vital high-tech equipment and key research being undertaken at the centre has also been generously provided by local medical charity, the Daisy Appeal.

Dr Allam said: “I have long been a supporter of medical research because I want my donations to make the biggest impact on peoples’ lives that they possibly can.

“I believe wholeheartedly that medical research, and particularly research into society’s most prevalent killers such as cancer and heart disease, is the best way to ensure this happens. After all, these conditions touch everyone, old or young, rich or poor and all nationalities.

“It was an honour to have provided the money to create such a wonderful facility and it is an honour for me that it bears my name. I am extremely proud to see it finally completed.

“The Allam Building will not only help the University of Hull remain at the forefront of cutting edge medical research, it will lead to more lives being saved and money can be put to no better purpose than that.”

University of Hull Vice-Chancellor, Professor Calie Pistorius, said: “The University of Hull is very proud of this state-of-the-art facility, which not only brings together expertise from across the region to benefit patients, but helps us strengthen our position as a centre of research excellence.

“This is one of many initiatives which the University is implementing to further enhance the quality of our student experience and our international reputation.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Unkempt Weedy Land Unintentionally Boosts Wildlife
Parts of the farm landscape that look overgrown and ‘scruffy’ are more important than they first appear in supporting wildlife.
Wednesday, May 22, 2013
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Researchers Develop Software That Could Facilitate Drug Development
AptaTRACE can identify aptamers, potentially speed drug advancement.
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Zika Vaccine Candidates Show Promise
Two experimental vaccines have shown promise against a major viral strain responsible for the Brazilian Zika outbreak.
New Medication Shows Promise Against Liver Fibrosis in Animal Studies
Liver fibrosis is a gradual scarring of the liver that puts people at risk for progressive liver disease and liver failure.
Raw Eggs Deemed Safe to Eat
A report published today by the Advisory Committee on the Microbiological Safety of Food (ACMSF) into egg safety has shown a major reduction in the risk from salmonella in UK eggs.
Monitoring TTX Toxin in Shellfish
In a number of small studies, mussels and oysters from the eastern and northern part of the Oosterschelde in Holland were found to contain tetrodotoxin (TTX).
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!